Pharmaceutical and biotech companies all over the world trust us to perform comprehensive audits to the latest GMP regulations and expectations, and to work with them in the development, implementation and verification of corrective action plans (CAPs) that are comprehensive, compliant and sustainable.
At NSF Health Sciences Pharma Biotech, we can assess any type of activity against all major international regulatory and GMP standards, including EU, USA, Canada, Australia, WHO and more. Rather than simply telling you where you fail to comply, we provide essential, pragmatic advice on how to achieve compliance in a cost-effective way. Our team of former regulatory inspectors and industry experts can assist you by performing audits to any current Good Manufacturing Practice (cGMP) standard for production, packing, testing, storage and distribution, engineering, software, water systems, autoclaves, raw material suppliers and many other vendor and supplier services.
Whether you are looking for an in-depth, expert assessment of a specific technical issue, to outsource your entire supplier audit program or anything in between, we can help.
- 1 week ago
FDA Regulatory and Compliance News FDA announced the approval of Bayer HealthCare Pharmaceuticals’ Avelox (moxifloxacin) to treat patients with pneumonic...
- 2 weeks ago
FDA Regulatory and Compliance News FDA republished in its entirety a final order entitled, “Medical Devices; Physical Medicine Devices; Classification...
- 4 weeks ago
Effective immediately, the NSF International business unit formerly known as International Pharmaceutical Excipient Auditing, Inc. (IPEA) has been renamed NSF...
- Monday, June 1, 2015
- 8:30am - 4:00pm GMT
- Manchester, United Kingdom
- Tuesday, June 2, 2015
- 9:00am - 3:00pm GMT
- Manchester, UK, United Kingdom
- Thursday, June 4, 2015
- 8:30am - 3:00pm GMT
- York, United Kingdom
- Thursday, June 11, 2015
- 1:00pm - 2:00pm GMT
- Webinar, United Kingdom